Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05229952 · ClinicalTrials.gov registry record · NA

Assessment of Endogenous Oxalate Synthesis

A NA study of Healthy and Obesity, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT05229952 is a NA study of Healthy and Obesity that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 23 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05229952, a NA study of Healthy and Obesity, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.

Interventions

  • DIETARY_SUPPLEMENT Low-oxalate controlled diet
  • OTHER Primed, continuous intravenous infusion of 13C2-oxalate

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2022-02-10
Est. Completion 2024-09-09
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05229952

The ClinicalTrials.gov registry entry for NCT05229952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Low-oxalate controlled diet is the first listed.

NCT05229952 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05229952 about?

NCT05229952 is a clinical study titled "Assessment of Endogenous Oxalate Synthesis". This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.

What is the current status of trial NCT05229952?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-02-10. Estimated completion is 2024-09-09.

What conditions does trial NCT05229952 study?

This clinical trial studies the following conditions: Healthy, Obesity, Kidney Stone.

What interventions are being tested in trial NCT05229952?

The interventions under investigation include: Low-oxalate controlled diet (DIETARY_SUPPLEMENT), Primed, continuous intravenous infusion of 13C2-oxalate (OTHER).

Who is sponsoring clinical trial NCT05229952?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05229952 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.